Varaico: Literature-Extracted Genetic Variants

Gene:RUNX3
Variant:p.R122C
Back to variants list

RUNX3

NM_004350.3:p.R122C

Associated Papers

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade.

Oei V et al.

Communications Biology, 2023

The RUNX Family of Proteins, DNA Repair, and Cancer.

Krishnan V

Cells, 2023

RUNX3 in Stem Cell and Cancer Biology.

Chuang LSH et al.

Cells, 2023

A Point Mutation R122C in RUNX3 Promotes the Expansion of Isthmus Stem Cells and Inhibits Their Differentiation in the Stomach.

Douchi D et al.

Cellular and Molecular Gastroenterology and Hepatology, 2022

The Multifaceted Role of TGF-β in Gastrointestinal Tumors.

Sabbadini F et al.

Cancers, 2021

RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.

Qiao Y et al.

Oncogene, 2016

Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2.

Ozaki T et al.

Biomolecules, 2015

RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation.

Kim JH et al.

Oncogenesis, 2014

Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.

Ju X et al.

Cancer Science, 2014

RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response.

Ozaki T et al.

International Journal of Genomics, 2013

Association of caspase-9 and RUNX3 with inflammatory bowel disease.

Guo C et al.

Tissue Antigens, 2011

RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.

Yamada C et al.

The Journal of Biological Chemistry, 2010

Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.

Lee CW et al.

Cancer Research, 2010

Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis.

Gao L et al.

European Journal of Human Genetics : Ejhg, 2009

Molecular pathology of RUNX3 in human carcinogenesis.

Subramaniam MM et al.

Biochimica Et Biophysica Acta, 2009

Genetic variants in the Runt-related transcription factor 3 gene contribute to gastric cancer risk in a Chinese population.

Wu D et al.

Cancer Science, 2009

Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.

Zhang Z et al.

Carcinogenesis, 2008

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Kim WJ et al.

Cancer Research, 2005

Redefining tumour suppressor genes: exceptions to the two-hit hypothesis.

Paige AJ

Cellular and Molecular Life Sciences : Cmls, 2003

Causal relationship between the loss of RUNX3 expression and gastric cancer.

Li QL et al.

Cell, 2002

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."